Background: The role of leptin in polycystic ovarian syndrome (PCOS) is unclear. We investigated the relationship between serum leptin levels, body composition and insulin resistance in polycystic ovarian syndrome (PCOS). Methods: We analyzed differences between 27 patients with PCOS and 25 control subjects in serum glucose and leptin levels, insulin resistance, body fat mass, lean body mass, and water volume. Results: Serum leptin was significantly correlated with basal insulin levels, BMI and IR in both groups (P<0.01). Fat mass, fat percentage, lean mass and water volumes were positively correlated and lean percentage and water percentage were negatively correlated with leptin levels (P<0.05). Leptin levels were significantly different between the groups in a multivariate regression analysis after correcting for the difference in BMI and body fat percentage (P<0.05). When the effects of fat percentage on serum leptin were eliminated, the levels were significantly different between the PCOS and control groups, and were statistically more powerful than BMI(/><0.01). Conclusion: These findings support the idea that factors other than excess fat mass or fat-free mass might be important in the regulation of serum leptin levels in PCOS.
L eptin, predom inantly produced by adipocytes, is a polypeptide horm one essential in the regulation o f normal body w eight.1 T he production o f leptin is under neuroendocrine control and leptin receptors are found in various endocrine organs, including the pancreas and ovaries.2 However, the role o f leptin in reproductive function as well as the interaction between reproduction and nutrition are not yet clear.2'8 T he role o f leptin in polycystic ovarian syndrome (PCOS) is under investigation since the disease involves im pairm ent o f reproduction and nutrition. Recent studies have reported the interesting finding that insulin sensitizers could influence the pathophysiology o f PCO S, decreasing serum leptin as well as insulin levels and resulting in improvements in reproductive functions.2,7 We investigated circulating leptin levels and their relationship w ith the am ount and percentage o f body fat as well as insulin and glucose levels during a standard 75-gram oral glucose tolerance test (O G T T ) in infertile patients w ith PCO S.
Methods
Twenty-seven women w ith the diagnosis o f PCO S attending our infertility clinic made up the study group. T he diagnosis o f PCO S was based on 1) oligomenorrhea or am enorrhea or 2) anovulation (<3 ng/m L mid-luteal progesterone levels) and 3) ultrasound evidence o f bilateral enlarged polycystic ovaries. Ovulatory partners o f 25 infertile couples were included as control subjects. Informed consent was obtained from patients and controls for participation in the study.
A 2-hour 75-gram O G T T was perform ed for each case after overnight fasting, following a 3-day standardized high carbohydrate diet. Insulin and glucose levels were measured initially and at 60 and 120 minutes. Initial blood samples for O G T T were obtained between 8:30 AM and 10:00 AM. Insulin resistance (IR) was calculated w ith the formula for Homeostasis Model Assessment (H O M A IR = fasting serum insulin (pU/mL) x fasting plasma glucose [mmol/L]/22.5). Body mass index (BMI) was calculated for each case as weight (in kilograms) divided by height (in meters) squared. Each case underwent bioelectric impedance (BEI) analysis to estimate body composition. Resistance and reactance were measured w ith the subject lying supine by use o f an impedance analyzer with two body surface electrodes and a conduction current less than 1 pA and 50 kH z (Bodystat 1500, Body Com position Analyzer). O ne surface electrode was placed on the dorsal surface o f the right hand and one on the dorsal surface o f the right foot. Body fat and lean body mass (fatfree mass) and their percentage values were automatically calculated by the analyzer. W ater volume and percentage o f water were also obtained w ith the same analyzer.
H orm onal and biochemical determinations were performed at the Central Laboratory o f the Medical Faculty, O ndokuz Mayis University. Insulin levels were measured using the Im m ulite 2000 im m unom etric method. Leptin measurements were obtained with the D SL-10-23100 H um an Leptin ELISA kit by ELISA technique. H orm onal evaluations as well as the BEI analyses were made in the early follicular phase in all the control cases and if possible in the PCO S cases; otherwise they were made randomly in severe oligomenorrheic or amenorrheic women.
D ata were analyzed w ith the SPSS statistical package program. T he M ann-W hitney test was used for comparing groups and Pearson correlation analysis to test for correlations. Multivariate regression analyses were performed to evaluate the effects o f certain parameters on serum leptin levels in PCO S. A P value <0.03 was considered statistically significant.
Results
T he differences in leptin levels, basal insulin levels, IR and BMI between the PCO S and control groups were statistically significant (Table 1) . Body fat mass, lean body mass, water content and the percent values were also significantly different. There was no correlation between leptin levels and age, except for the control group (/VO.05) ( Table 2 ). Leptin levels correlated with basal insulin levels, BMI and IR in the PCO S and control groups and overall (Table 2) .
In the multivariate analysis, leptin levels were significantly increased in the PCO S group compared w ith the control group even when the effects o f BMI and body fat mass were eliminated. T he effect o f BMI on leptin levels appeared to be considerably stronger than the effect o f the body fat mass (/V 0.01 and / )<0.05, respectively). T he difference between groups for IR was significant when the effect of body fat was eliminated, but this was not the case when the effect o f BMI was disregarded.
Body fat mass, fat percentage, lean body mass and water volumes were positively correlated and lean percentage and water percentage were negatively correlated w ith leptin levels in all cases when study and control groups were considered together (/V 0.05) ( Table 2 ). W hen the PCO S and control groups were analyzed separately, all the previously significant correlations disappeared in the PCO S group, but persisted in the control group, except for water percentage (Table  2 ). There was a negative correlation between impedance and leptin levels, which was again significant in the control group, but not in the PCO S group.
Discussion
Leptin, a horm onal product of the ob (obese) gene, is expressed by adipocytes and is thought to play a role in the regulation o f food intake and metabolism. Leptin might serve as a permissive signal for the reproductive system.4 Leptin levels are not constant and may vary w ith follicular growth and m aturation and thus fluctuate throughout the menstrual cycle.9 Additionally, nocturnal changes in luteinizing horm one pulse parameters are associated temporarily with the rise o f plasma concentrations o f leptin at night, and the fluctuations o f plasma leptin concentrations are synchronous w ith those o f LH and estradiol.10 In our study, we investigated basal leptin levels in the m orning and in the early follicular phase o f the menstrual cycle, except in patients w ith steady-state horm onal status.
T he consensus is that leptin levels are high in PCOS patients,711,12 but the data on the relationship o f leptin and fat distrubution in PCO S syndrome are conflicting. 13 In our study, we observed that serum leptin levels as well as basal insulin levels, IR and BMI were significantly high in PCOS patients. This is in accordance w ith reports in the literature that show that leptin is strongly correlated with M I.5,6'111214 A lthough leptin production mainly occurs in adipose tissue, when the difference in body fat mass between PCO S and controls was corrected for, the difference in the leptin levels remained significant. This finding makes us think that there m ight be other reasons for the increase in the serum leptin concentration in PCO S cases. O u r observation was in contrast with a previous article, which reported that serum leptin concentrations were almost exclusively determined by the am ount o f body fat.6 O n the other hand, there are also data in the literature on the relationship between leptin and fertility that support our observations: Serum leptin levels decreased significantly after 2 m onths o f m etformin treatm ent in obese PCO S patients. 15 Those authors suggested that the decrease in leptin could not, however, be explained by the changes in body weight, because the BMI o f their patients remained constant during therapy. 15 Imani et al showed that the prediction o f which patients would be anovulatory after clomiphene citrate medication could be slightly improved (area under curve increased from 0.82 to 0.83) by using leptin instead of BMI or the waistto-hip ratio . 16 This may indicate that leptin is more directly involved with the ovarian function or dysfunction in these patients. According to Fedorcsak, obesity directly affects ovarian function in PCO S at least in part by increased intrafollicular leptin levels, and may induce a relative resistance to gonadotropin stim ulation.17 However, the discussion is not over yet. 18 We found that leptin levels were higher along w ith body fat mass and fat percentage in the PCO S group compared to the control group, as would be expected since plasma leptin levels tend to increase in parallel w ith adipose stores and are strongly correlated with body fat mass.19 However, others argue that the large variation in circulating leptin concentrations at similar levels o f adiposity indicates that factors other than fat mass may be im portant in regulating serum leptin.19 This argument was supported by our study as well, with the observation that the body fat mass-leptin correlation in our PCOS group disappeared. We also agree with Laughlin et al, who speculated that the opposing effects o f hyperinsulinemia (stimulatory) and adipocyte IR (negative) specific to PCO S might negate the impact of insulin excess and account for the maintenance of normal levels o f serum leptin in PC O S/' Body fat mass and fat percentages were positively correlated with leptin levels and, as expected, lean body mass percentage was negatively correlated. Interestingly, lean body mass (fat-free mass) was positively correlated with leptin levels. All o f these relationships were absent in the PCO S group, a finding consistent with the report that leptin positively correlated with the fat-free mass in men fPcO.Ol) but not in w om en20 CP>0.05).
Jinno et al investigated bioelectrical impedance (BEI) as a novel m ethod for assessing assisted female fertility.21 In the stepwise logistic regression analysis o f five factors (BEI on luteal day 4 prior to the IVF cycle [BEI-L4], age, basal FSH, body height and BMI), BEI-L4 alone appeared to be a significant predictor (P<0.05) o f achievement of pregnancy by IVT.21 In our study, we did not find a significant difference between the early follicular phase BEI values o f PCOS and control subjects. Leptin and BEI findings were correlated in the overall and the control group, but disappeared in the PCOS patients, as did the other fat distribution parameters.
High serum leptin, insulin and testosterone levels together with reduced insulin sensitivity have been observed in obese PCOS women, suggesting that high leptin levels could be characteristic o f the obese PCOS phenotype.1^ In this study, we also found that the degree o f IR was higher in PCOS despite the adjustment o f the body fat mass between the two groups.
In summary, we found positive correlations between leptin and body fat mass, fat percentage and a negative correlation with fat-free mass percentage. Interestingly, there was also a positive correlation with fat-free mass. N one o f these correlations could be demonstrated in the PCOS patients alone, suggesting that factors other than excess fat and excess fat-free mass may be im portant in the regulation o f serum leptin, and consequently, female reproductive function.
